Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants
Clinical trial NCT05037409 · COMPLETED
Trial details
- NCT number
- NCT05037409
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2022-03-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.